Evaluating Healthcare AI: ROI, Safety, and Outcomes

Healthcare organizations should not label every desirable effect “return on investment.” Financial ROI, budget impact, cost-effectiveness, clinical outcomes, workflow, safety, equity, patient experience, and workforce experience answer different questions. Report them separately under one evaluation plan.

For a stated perspective and time horizon:

ROI = (attributable financial benefits - total attributable costs) / total attributable costs

Include acquisition, integration, local validation, workflow redesign, training, support, monitoring, cybersecurity, governance, updates, downtime, incident response, and retirement. Attribution requires a credible comparator.

Define the intervention

Document model/software version, intended use, population, setting, inputs, output, user, action triggered, fallback, and place in the care pathway. State whether it is administrative, operational, patient-facing, diagnostic, prognostic, monitoring, or treatment-related. Authorization does not prove local clinical or economic value.

Use a multidimensional scorecard

Dimension	Measures	Qualification
Clinical effectiveness	Patient-relevant outcome, time to appropriate care	Comparator, population, follow-up, estimate and uncertainty
Safety	Misses, false escalation, delay, incidents and near misses	Severity, denominator, adjudication and subgroup
Equity	Access, error and outcome differences	Predefined groups, data limits and mitigation owner
Workflow	Task and queue time, override, alert burden, shifted work	Logs or time-and-motion definitions
Financial	Net cost, ROI, cash flow, avoided cost	Perspective, attribution, horizon and sensitivity analysis
Operational	Coverage, calibration, latency, uptime, drift	Version, slice, threshold, failure and rollback rules

Aggregate financial gain must not compensate for unacceptable safety or equity harm.

Choose a credible evaluation design

Use randomized, stepped-wedge, interrupted time-series, matched comparison, or other designs suited to the decision and deployment. Plain before/after comparisons are vulnerable to secular trends, case-mix changes, concurrent interventions, documentation changes, and regression to the mean. Report effect sizes and uncertainty; a p-value does not establish clinical importance or causality.

Evaluate the human-AI team, escalation, automation bias, workload displacement, and recovery from wrong outputs. Review evaluation design where language models are involved.

Protect patients and data

Apply permitted-use, minimization, access, provenance, retention, and deletion controls described in data-access governance. Test privacy, cybersecurity, interoperability, downtime, and fallback. Monitor performance and outcomes after release by relevant site and population.

Build a decision dossier

Record the comparator, perspective, time horizon, assumptions, costs, clinical endpoints, safety events, equity slices, uncertainty, conflicts, regulatory status, model version, deployment changes, and stop rules. Accurate supported coding—not a higher risk-adjustment score—is the defensible target.

Assign decision rights through an AI-governance framework. Reassess after model, workflow, population, data, vendor, or reimbursement changes, and retire systems whose benefits no longer outweigh costs and harms.

Reviewed and substantially updated September 4, 2026. Original publication date preserved.